PE20141001A1 - Metoclopramida de liberacion prolongada de 24 horas - Google Patents
Metoclopramida de liberacion prolongada de 24 horasInfo
- Publication number
- PE20141001A1 PE20141001A1 PE2014000265A PE2014000265A PE20141001A1 PE 20141001 A1 PE20141001 A1 PE 20141001A1 PE 2014000265 A PE2014000265 A PE 2014000265A PE 2014000265 A PE2014000265 A PE 2014000265A PE 20141001 A1 PE20141001 A1 PE 20141001A1
- Authority
- PE
- Peru
- Prior art keywords
- prolonged release
- methchlopramide
- pharmaceutical composition
- cross links
- sodium
- Prior art date
Links
- 230000002035 prolonged effect Effects 0.000 title abstract 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 208000018522 Gastrointestinal disease Diseases 0.000 abstract 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 abstract 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 abstract 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 abstract 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 abstract 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 1
- 229920000881 Modified starch Polymers 0.000 abstract 1
- 239000001913 cellulose Substances 0.000 abstract 1
- 229920002678 cellulose Polymers 0.000 abstract 1
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 1
- 239000000194 fatty acid Substances 0.000 abstract 1
- 229930195729 fatty acid Natural products 0.000 abstract 1
- 150000004665 fatty acids Chemical class 0.000 abstract 1
- 229940075507 glyceryl monostearate Drugs 0.000 abstract 1
- 229920001477 hydrophilic polymer Polymers 0.000 abstract 1
- 229920001600 hydrophobic polymer Polymers 0.000 abstract 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 abstract 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 abstract 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 abstract 1
- 229920000609 methyl cellulose Polymers 0.000 abstract 1
- 239000001923 methylcellulose Substances 0.000 abstract 1
- 235000010981 methylcellulose Nutrition 0.000 abstract 1
- TTWJBBZEZQICBI-UHFFFAOYSA-N metoclopramide Chemical compound CCN(CC)CCNC(=O)C1=CC(Cl)=C(N)C=C1OC TTWJBBZEZQICBI-UHFFFAOYSA-N 0.000 abstract 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 abstract 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 abstract 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 abstract 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 abstract 1
- 229910052708 sodium Inorganic materials 0.000 abstract 1
- 239000011734 sodium Substances 0.000 abstract 1
- 229920003109 sodium starch glycolate Polymers 0.000 abstract 1
- 229940079832 sodium starch glycolate Drugs 0.000 abstract 1
- 239000008109 sodium starch glycolate Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Otolaryngology (AREA)
- Hospice & Palliative Care (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
SE REFIERE A UNA COMPOSICION FARMACEUTICA DE LIBERACION PROLONGADA QUE COMPRENDE: A) DE 21 A 35 MG DE CLORHIDRATO DE METOCLOPRAMIDA; Y B) DE 179 A 165 MG DE i) UN POLIMERO HIDROFILICO TAL COMO METILCELULOSA, HIDROXIETILCELULOSA, HIDROXIPROPILCELULOSA O HIDROXIPROPILMETILCELULOSA; ii) UN POLIMERO HIDROFOBICO TAL COMO ETILCELULOSA, GLICERIL MONOESTEARATO O ACIDOS GRASOS; Y iii) UN COMPONENTE HIDROFILICO TAL COMO CARBOXIMETILCELULOSA DE SODIO CON ENLACES ENTRECRUZADOS, POLIVINILPIRROLIDONA CON ENLACES ENTRECRUZADOS, ALMIDON GLICOLATO DE SODIO, ALMIDON PREGELATINIZADO O CELULOSA MODIFICADA. DICHA COMPOSICION FARMACEUTICA ES UTIL EN EL TRATAMIENTO DE TRASTORNOS GASTROINTESTINALES
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MX2008004268A MX2008004268A (es) | 2008-03-28 | 2008-03-28 | Metoclopramida de liberacion prolongada de 24 horas. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20141001A1 true PE20141001A1 (es) | 2014-08-25 |
Family
ID=41114143
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2009000458A PE20091737A1 (es) | 2008-03-28 | 2009-03-27 | Metoclopramida de liberacion prolongada 12 horas |
| PE2014000265A PE20141001A1 (es) | 2008-03-28 | 2009-03-27 | Metoclopramida de liberacion prolongada de 24 horas |
| PE2009000459A PE20091824A1 (es) | 2008-03-28 | 2009-03-27 | Metoclopramida de liberacion prolongada de 24 horas |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2009000458A PE20091737A1 (es) | 2008-03-28 | 2009-03-27 | Metoclopramida de liberacion prolongada 12 horas |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2009000459A PE20091824A1 (es) | 2008-03-28 | 2009-03-27 | Metoclopramida de liberacion prolongada de 24 horas |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20110033536A1 (es) |
| AR (1) | AR071571A1 (es) |
| BR (1) | BRPI0906346A2 (es) |
| CA (1) | CA2757023C (es) |
| CL (1) | CL2009000775A1 (es) |
| CO (1) | CO6311074A2 (es) |
| MX (1) | MX2008004268A (es) |
| PE (3) | PE20091737A1 (es) |
| WO (1) | WO2009120054A1 (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2008004267A (es) * | 2008-03-28 | 2009-09-28 | Posi Visionary Solutions Llp | Metoclopramida de liberacion prolongada de 12 horas. |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2492661A1 (fr) * | 1980-10-28 | 1982-04-30 | Laruelle Claude | Nouvelle forme galenique d'administration du metoclopramide, son procede de preparation et medicament comprenant cette nouvelle forme |
| FR2576213B1 (fr) * | 1985-01-21 | 1989-02-24 | Cortial | Nouveau procede d'obtention de formes pharmaceutiques a liberation prolongee |
| JPS6261916A (ja) * | 1985-09-12 | 1987-03-18 | Fujisawa Pharmaceut Co Ltd | 持続性製剤 |
| GB8613688D0 (en) * | 1986-06-05 | 1986-07-09 | Euro Celtique Sa | Pharmaceutical composition |
| US6372254B1 (en) * | 1998-04-02 | 2002-04-16 | Impax Pharmaceuticals Inc. | Press coated, pulsatile drug delivery system suitable for oral administration |
| US6770262B2 (en) * | 2000-03-30 | 2004-08-03 | Questcor Pharmaceuticals, Inc. | Nasal administration of agents for the treatment of gastroparesis |
| KR20040106422A (ko) * | 2002-05-01 | 2004-12-17 | 노파르티스 아게 | 간암 및 다른 암 질병 치료용 에포틸론 유도체 |
| US20070196481A1 (en) * | 2002-07-25 | 2007-08-23 | Amidon Gregory E | Sustained-release tablet composition |
| GB0317904D0 (en) * | 2003-07-31 | 2003-09-03 | Jagotec Ag | Improvements in or relating to organic compounds |
-
2008
- 2008-03-28 MX MX2008004268A patent/MX2008004268A/es active IP Right Grant
-
2009
- 2009-03-27 US US12/935,187 patent/US20110033536A1/en not_active Abandoned
- 2009-03-27 WO PCT/MX2009/000026 patent/WO2009120054A1/es not_active Ceased
- 2009-03-27 PE PE2009000458A patent/PE20091737A1/es not_active Application Discontinuation
- 2009-03-27 CA CA2757023A patent/CA2757023C/en active Active
- 2009-03-27 PE PE2014000265A patent/PE20141001A1/es not_active Application Discontinuation
- 2009-03-27 BR BRPI0906346A patent/BRPI0906346A2/pt not_active Application Discontinuation
- 2009-03-27 AR ARP090101110A patent/AR071571A1/es not_active Application Discontinuation
- 2009-03-27 CL CL2009000775A patent/CL2009000775A1/es unknown
- 2009-03-27 PE PE2009000459A patent/PE20091824A1/es active IP Right Grant
-
2010
- 2010-10-22 CO CO10130863A patent/CO6311074A2/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| PE20091824A1 (es) | 2009-11-25 |
| BRPI0906346A2 (pt) | 2016-07-26 |
| WO2009120054A1 (es) | 2009-10-01 |
| CA2757023A1 (en) | 2009-10-01 |
| CO6311074A2 (es) | 2011-08-22 |
| PE20091737A1 (es) | 2009-11-25 |
| CA2757023C (en) | 2017-09-05 |
| CL2009000775A1 (es) | 2009-09-25 |
| US20110033536A1 (en) | 2011-02-10 |
| MX2008004268A (es) | 2009-09-28 |
| AR071571A1 (es) | 2010-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR082861A1 (es) | Forma de dosificacion resistente a alteracion que comprende un polimero anionico | |
| GT200900095A (es) | Dihidropirazolonas sustituidas para el tratamiento de enfermedades cardiovasculares y hermatologicas. | |
| ECSP088239A (es) | Composición de liberación de fármaco sostenida | |
| EA201071144A1 (ru) | Гетероциклические производные | |
| MX2010007295A (es) | Composiciones acuosas estables de ciclosporina. | |
| UA105229C2 (uk) | Фармацевтичний склад | |
| CO6362012A2 (es) | Clohidarto de nalmefeno dihidratado | |
| GT201100336A (es) | Sulfonamidas heterocíclicas, usos y composiciones farmacéuticas de las mismas | |
| BR112012013487A2 (pt) | Composições de amantadina e métodos de uso | |
| DOP2010000232A (es) | Derivados de indazol | |
| PE20081106A1 (es) | Comprimidos pediatricos de capecitabina | |
| PE20130379A1 (es) | Metodos para el tratamiento de las ulceras del pie diabetico | |
| PE20060768A1 (es) | Composicion farmaceutica que comprende hidroclorotiazida y telmisartano | |
| PL2244703T3 (pl) | Lekarstwo, jego wytwarzanie i zastosowanie w leczeniu bolesnych neuropatii | |
| CY1109865T1 (el) | Συνθεσεις βαλσαρτανης | |
| EA201071309A1 (ru) | Твердая фармацевтическая композиция | |
| PE20120421A1 (es) | Composicion farmaceutica que comprende aleglitazar | |
| UY30021A1 (es) | Formulación de suspensión de fexofenadina | |
| BR112013018688A2 (pt) | processo para a produção de composição polimérica de proantocianidina | |
| PE20130374A1 (es) | Composicion farmaceutica que comprende ibuprofeno | |
| PE20141001A1 (es) | Metoclopramida de liberacion prolongada de 24 horas | |
| GT200600277A (es) | Derivados de prostaglandina | |
| DOP2006000280A (es) | Nuevos derivados de furopirimidina acíclicos sustituidos y su uso | |
| ATE525349T1 (de) | Pharmazeutische prostaglandinzusammensetzungen | |
| TN2015000176A1 (fr) | Pastille medicamenteuse a base d'ibuprofene sodique dihydrate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal | ||
| AE | Restoration of lapsed or forfeited application | ||
| FC | Refusal |